4D Molecular Therapeutics, Inc.
FDMT
DELAYED 1 MONTH

1 insider filing · Latest: Jun 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 1, 2026Jun 2 8:48 PMKirn DavidDirector, President and Chief Executive Officer
Sale
1,922$10.02$19.3K1,057,231(D)

View →

Stock Options & Derivatives

No transactions found.